C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
1.420
-0.020 (-1.39%)
At close: Jun 20, 2025, 4:00 PM
1.410
-0.010 (-0.70%)
After-hours: Jun 20, 2025, 7:56 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $100.83 million as of June 20, 2025. Its market cap has decreased by -69.72% in one year.
Market Cap
100.83M
Enterprise Value
-70.22M
1-Year Change
-69.72%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $100.83M, a decrease of -86.95%. That is a compound annual growth rate of -35.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 102.25M | -59.76% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | 1.43B | 84.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.32B |
| Johnson & Johnson | 366.64B |
| Novo Nordisk | 334.60B |
| AbbVie | 327.63B |
| UnitedHealth Group | 280.19B |
| Abbott Laboratories | 230.15B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |